ICAM-1 and ICAM-2 Are Differentially Expressed and Up-Regulated on Inflamed Pulmonary Epithelium, but Neither ICAM-2 nor LFA-1: ICAM-1 Are Required for Neutrophil Migration Into the Airways In Vivo by Chong, DLW et al.
Frontiers in Immunology | www.frontiersin.
Edited by:
Janos G. Filep,










†These authors have contributed
equally to this work and
share first authorship
Specialty section:
This article was submitted to
Molecular Innate Immunity,
a section of the journal
Frontiers in Immunology
Received: 07 April 2021
Accepted: 29 June 2021
Published: 16 August 2021
Citation:
Chong DLW, Rebeyrol C, José RJ,
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Neutrophil migration into the airways is an important process to fight infection and is
mediated by cell adhesion molecules. The intercellular adhesion molecules, ICAM-1
(CD54) and ICAM-2 (CD102) are known ligands for the neutrophil integrins, lymphocyte
function associated antigen (LFA)-1 (aLb2; CD11a/CD18), and macrophage-1 antigen
(Mac-1;aMb2;CD11b/CD18) and are implicated in leukocyte migration into the lung.
However, it is ill-defined how neutrophils exit the lung and the role for ICAMs in trans-
epithelial migration (TEpM) across the bronchial or alveolar epithelium. We found that
human and murine alveolar epithelium expressed ICAM-1, whilst the bronchial epithelium
expressed ICAM-2, and both were up-regulated during inflammatory stimulation
in vitro and in inflammatory lung diseases such as cystic fibrosis. Although b2 integrins
interacting with ICAM-1 and -2 mediated neutrophil migration across human bronchial
epithelium in vitro, neither ICAM-2 nor LFA-1 binding of ICAM-1 mediated murine
neutrophil migration into the lung or broncho-alveolar space during LPS-induced
inflammation in vivo. Furthermore, TEpM of neutrophils themselves resulted
in increased epithelial junctional permeability and reduced barrier function in vitro. This
suggests that although b2 integrins interacting with ICAMs may regulate low levels of
neutrophil traffic in healthy lung or early in inflammation when the epithelial barrier is intact;
these interactions may be redundant later in inflammation when epithelial junctions are
disrupted and no longer limit TEpM.
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Neutrophilic inflammation underlies many chronic lung diseases
including cystic fibrosis (CF), bronchiectasis, and chronic
obstructive pulmonary disease (COPD) (1, 2). During
inflammation or infection, the movement of leukocytes such as
neutrophils from the blood across the endothelium is a highly-
organized process, consisting of well characterized steps of
capture, rolling, arrest, adhesion, crawling and finally
transmigration of leukocytes across the blood vessel wall (3).
Each of these steps is mediated via interactions between cell
adhesion molecules expressed by leukocytes and endothelial
cells, such as integrins, selectins, intercellular adhesion
molecules (ICAMs) and junctional adhesion molecules
(JAMs) (4).
The role of ICAM-1 (CD54) and ICAM-2 (CD102) in
mediating leukocyte trans-endothelial migration has been
studied. ICAM-1 is highly expressed on endothelial cells (5)
and is required for neutrophil adhesion and trans-endothelial
migration (6). ICAM-2 is also expressed on endothelial cells (7)
and mediates neutrophil crawling and subsequent extravasation
through the endothelium in vivo (8). Although we understand
the mechanisms of leukocyte trans-endothelial migration in
many organs, it is becoming clearer that leukocytes enter the
lung interstitium via different mechanisms (9, 10). Due to low
blood flow velocity and the small size of pulmonary capillaries,
neutrophils do not undergo the conventional rolling steps of
trans-endothelial migration (11). Therefore, different
mechanisms may occur to mediate leukocyte migration into
the lung in response to inflammation or infection.
Furthermore, the mechanisms by which leukocytes leave the
lung interstitium are unclear. In particular, the mechanisms of
trans-epithelial migration (TEpM) at the level of airways and/or
alveolar epithelia are ill-defined. In contrast to trans-endothelial
migration, leukocytes must cross the epithelial cell barrier in a
basolateral-to-luminal direction. Therefore, different cell
adhesion molecules may be required compared to trans-
endothelial migration. In addition, expression levels of cell
adhesion molecules on neutrophils are modulated as these cells
move out of the blood, through the interstitium and across the
lung epithelium (12). For example, the expression of lymphocyte
function-associated antigen (LFA)-1 (aLb2; CD11a/CD18) on
neutrophils decreases as they exit the blood into the airways,
whilst macrophage-1 antigen (Mac-1, aMb2; CD11b/CD18)
expression increased upon entering the lung interstitium and
decreased after crossing the bronchial epithelium (12).
Therefore, neutrophils arriving at the basolateral surface of the
epithelium may have altered activation status and different cell
adhesion ligands on epithelial cells may be required to
mediate TEpM.
Neutrophil TEpM into the bronchial airways and alveolar
airspaces is important to clear pathogens but may cause collateral
tissue damage (13). In a murine model of Pseudomonas
aeruginosa-induced pneumonia, neutropenic mice exhibited
increased mortality, emphasising the importance of neutrophil
recruitment into the lung for bacterial clearance (14). Migration
across the bronchial epithelium has also been proposed as aFrontiers in Immunology | www.frontiersin.org 2mechanism by which neutrophils and other inflammatory cells
are cleared from the interstitium. Eosinophils, unable to migrate
across the bronchial epithelium accumulate in the interstitium of
ICAM-2 deficient mice during allergic airway inflammation to
worsen airway inflammation (15). In contrast, Li et al. showed
that preventing neutrophils moving across the alveolar
epithelium, by reducing a chemokine gradient, reduced
mortality from pulmonary inflammation (16). This suggests
that the consequences of leukocyte migration across the
bronchial or the alveolar epithelium may vary and be
differentially regulated during inflammation.
Despite the exact mechanisms remaining unknown, there is
evidence to suggest a role for b2 integrins, such as LFA-1 and
Mac-1, interacting with epithelial ligands in mediating
neutrophil TEpM in vitro. Although there are discrepancies in
the literature. Three studies have shown that migration of human
neutrophils through monolayers of human airway epithelial cell
lines is reduced by pre-treatment with blocking antibodies
against ICAM-1 (17–19), which is contrasted by one study
showing no effect (20). In addition, we have previously shown
that adhesion of the b2 integrin, LFA-1, to ICAM-1 and ICAM-2
on the basolateral surface of the epithelium plays a role in T
lymphocyte migration (basal-to-apical) across a tight barrier of
bronchial epithelial cells (21). However, it is unclear if these
in vitro models accurately reflect the animal models of lung
inflammation. Therefore, we sought to investigate the expression
of ICAM-1 and ICAM-2 on bronchial and alveolar epithelia on
normal and inflamed lung and the role of these molecules in
mediating neutrophil TEpM in vitro and in vivo.MATERIAL AND METHODS
Antibodies
Bronchial epithelial cell cultures were incubated with 10 mg/ml of
the following functional blocking antibodies: ICAM-1 (clone 15.2,
a domain (D)-1 blocking antibody that inhibits LFA-1: ICAM-1
binding, GenTex, USA), ICAM-2 (clone CBR-IC2/2, GenTex),
VCAM-1 (clone BBIG-V1, R&D Systems, UK), CD29 (clone
P5D2, Santa Cruz biotechnology, USA), CD18 (clone TS1/18,
Biolegend, USA), CD11b (clone 2LP19c, Santa Cruz
biotechnology), CD49d/VLA-4 (clone HP2/1, GenTex) and
CD11a (clone 38, GenTex). Normal mouse IgG1 (Santa Cruz
biotechnology), and IgG2 (GenTex) were used as isotype controls.
Patient Samples, Cells, and Mice
Human neutrophils or lung tissue biopsies from healthy controls,
and CF or COPD patients were collected with local written
consent and ethical approval from the UK National Research
Ethics Committee (13/LO/0900). Human bronchial epithelial
cells (HBECs) were cultured from explants and passaged as
previously described (22). Human umbilical vein endothelial
cells (HUVECs) were purchased from a commercial source
(Lonza, UK) and passaged according to supplier’s guidance.
16HBE14o- cells (a human bronchial epithelial cell line) were
cultured in aMEM supplemented with 10% FBS, 2 mM
L-glutamine, and 1% penicillin/streptomycin (ThermoFisherAugust 2021 | Volume 12 | Article 691957
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mycoplasma contamination by PCR. All animal studies were
ethically reviewed and conducted in line with UK Home Office
Regulations. C57BL/6 ICAM-2+/+ (WT) and ICAM-2-/- (KO)
mice (15) were housed and maintained at University College
London, with accordance to UK Home Office Regulations.
Immunohistochemistry and
Immunofluorescence Staining
Paraformaldehyde (PFA) fixed human or murine lung biopsies
were embedded in paraffin wax and 5 mm sections cut for IHC or
IF staining. Heat-induced epitope retrieval with citrate buffer, pH
6.0 or Tris-EDTA buffer, pH 9.0 was performed with murine lung
sections prior to blocking with 4% goat serum/1% BSA/PBS and
staining with ICAM-1 (clone YN1/1.7.4, ThermoFisher Scientific),
ICAM-2 (clone EPR18231-183, Abcam, UK) or rat or rabbit IgG
isotype control (Abcam) antibodies. Human lung sections were
stained with ICAM-1 (clone 15.2, ThermoFisher Scientific),
ICAM-2 (clone CBR-IC2/2, ThermoFisher Scientific) or CK5
(clone 34bE12, Abcam) antibodies. For IHC studies, sections
were developed using HRP-conjugated secondary antibodies,
NovaRED Peroxide (HRP) substrate kit (Vector Laboratories,
UK) and counter-stained with haematoxylin using an automated
slide stainer (Sakura Tissue-Tek DRS 2000). For IF studies,
fluorescently-conjugated secondary antibodies were used,
followed by nuclear DAPI staining. IHC sections were scanned
on a Nanozoomer Digital Slide Scanner and images analysed using
NDP.view software (Hamamatsu Corporation, Japan). IF sections




Trans-well permeable inserts with 5 mm pores (Millipore, UK)
were pre-coated overnight with 250 mg/ml type IV collagen
(Sigma-Aldrich, UK). The following day, trypsinized
16HBE14o- cells were diluted to a concentration of 1x106 cells/
ml and stained with Vybrant DiD fluorescent cell labelling dye
(ThermoFisher Scientific) for 20 min at 37°C. Cells were washed
three times with aMEM and resuspended at 1.5x106 cells/ml.
75 ml of cell suspension was seeded on to inverted trans-wells and
allowed to adhere for 4 h at 37°C, 5% CO2. Trans-wells were
loaded into 24-well receiver plates with 900 µl of growth medium
in the outer well (apical side of epithelium) and 200 µl in the
insert of the trans-well (basal side of the epithelium). Medium
was replaced every 2 days. After 6 days expansion, cells were
transferred to ALI culture, by rinsing trans-wells with PBS and
adding 300 µL aMEM to the apical side. 16HBE cells were
cultured in ALI for 7 days. Unstained HBECs were also seeded
on to trans-well as described above and were cultured at ALI for
21 days. In later experiments, epithelial cells were pre-treated
with 50 ng/ml TNF-a (R&D systems) for 24 h.
Quantitative PCR
Total RNA was extracted from epithelial cells using acidic phenol
method with chloroform and TRIzol (Invitrogen, UK) prior to
conversion into cDNA with qScript Reverse TranscriptaseFrontiers in Immunology | www.frontiersin.org 3(Quantabio, USA). qPCR was performed with Taqman pre-
designed ICAM-1 and ICAM-2 probes and Sybr-green
(Applied Biosystems, UK) using an Eppendorf real-plex
Mastercycler PCR machine (Eppendorf, USA). All samples
were run in duplicate and fold change in gene expression was
determined based on DCt calculations compared against b2-
microglobulin and GAPDH reference genes as controls.
Neutrophil Isolation and TEpM Assay
Human neutrophils from peripheral blood from healthy controls
were isolated by dextran/saline red blood cell sedimentation,
followed by gradient centrifugation using Percoll (Sigma-
Aldrich) and erythrocyte hypotonic lysis. Neutrophils were
labelled with 1 mM CMFDA fluorescent dye (ThermoFisher
Scientific) in HBSS without Ca2+ and Mg2+ (HBSS-) for
30 min at 37°C. Cells were washed in HBSS- and resuspended
at 5x106 cells/ml in HBSS with Ca2+ and Mg2+ (HBSS+).
Bronchial epithelial ALI cultures were washed in HBSS+ prior
to use. To assess neutrophil TEpM, 100 ng formylmethionyl-
leucyl-phenylalanine (fMLP; Sigma-Aldrich) in HBSS+ was
added to the outer well and 5x105 labelled neutrophils added
to the trans-well. Neutrophils were left to migrate for 3 h at 37°C,
5% CO2. In inhibition studies, neutrophils were pre-treated at
4°C with 10 mg/ml of blocking antibodies, isotype control
antibodies or HBSS- for 30 min. Blocking antibodies against
cell adhesion molecules expressed on bronchial epithelial cells
were add to the top of the trans-well (basolateral side) for 30 min
before washing with HBSS+ and neutrophils added to the
trans-well for TEpM. After neutrophil migration, to detach
transmigrated neutrophils adherent to the epithelial layer,
30 ml 0.5 M EDTA was added to each well and incubated for
10 min at 4°C. Detached cells in the outer wells were removed
and rinsed with HBSS+ prior to fixation with 2% PFA and
CMFDA+ Vybrant DiD- neutrophils were counted using a BD
Bioscience FACSVerse flow cytometer (BD Biosciences, UK) and
analysed with FlowJo Version 10 software (FlowJo, USA)
(Supplemental Figure 1 for gating strategy). The percentage of
transmigrated neutrophils was calculated relative to the number
of unstimulated neutrophils that had migrated through
untreated monolayers towards fMLP (control group).
Mouse Models of LPS-Induced Sterile
Inflammation or Pneumococcal Infection
8-14 week old male and female C57BL/6 ICAM-2+/+ (WT) or
ICAM-2-/- (KO) mice were used for in vivo studies. To induce
sterile inflammation in the lung, mice were randomised into 2
treatment groups and given 3.3 mg/mouse LPS (Sigma-Aldrich)
in a volume of 50 ml PBS or PBS only via an intra-nasal route.
Mice were monitored for disease severity and culled at an
established humane endpoint. Broncho-alveolar lavage fluid
(BALF) was obtained from 3 washes of 1 ml PBS and
centrifuged for 5 min at 300 g. BALF cells were counted by
cyto-centrifugation. Lungs were harvested and homogenized in
PBS to obtain a single cell suspension before erythrocyte
hypotonic lysis and staining with Ly6G-APC-Cy7 (clone 1A8),
Ly6C-V450 (clone AL-21), CD11b-PerCP-5.5 (clone M1/70),
CD11c-PE-Cy7 (clone HL3), MHCII-PE (clone M5/114.15.2)August 2021 | Volume 12 | Article 691957
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antibodies. Cells were fixed in 2% PFA and read on a flow
cytometer and analysed using FlowJo software (Supplemental
Figure 2 for gating strategy). For pneumococcal infection
experiments, mice were given 3-5x106 CFU Streptococcus
pneumoniae 19F isolate via an intranasal route. Cellular
recruitment into the BALF or lung was quantified as described
above (Supplemental Figure 3). For in vivo ICAM-1 blocking
studies, mice were given 2 doses of 3 mg/kg ICAM-1 blocking
(clone KAT-1, a D-1 blocking antibody) or IgG2a isotype control
antibody (Biolegend) (23) via intra-peritoneal route 1 day prior
and on the day of LPS or pneumococcal challenge.
Trans-Epithelial Electrical Resistance
and Cell Permeability
TEER and cell permeability to sodium or dextran conjugated
with fluorescein was assessed in bronchial cell monolayers. TEER
measurements were conducted using an STX2 electrode and
EVOM2 meter (World Precision Instruments, USA). The STX2
electrode was equilibrated in HBSS- prior to TEER values taken
by a 4-point measurement system on trans-well inserts. Type IV
collagen coated inserts without cells were used as background
controls. Permeability to 100 mg/ml of sodium-fluorescein
(376.27 Da) or 250 µg/ml of fluorescein-dextran (3 KDa)
solutions (both from Sigma-Aldrich) was assessed by loading
200 ml fluorescein conjugated molecules into the apical side of
the insert and allowing to permeate to the basolateral side from
30 min to 3 h at 37°C, 5% CO2. 100 ml samples were collected
from the basolateral side for fluorometric analysis using 485nm
excitation and 590nm emission filters. Concentrations were
obtained from a standard curve with diluted fluorescein
conjugated solution. Permeability was determined using the
equation: (dQ/dt)/C0*A), where dQ/dt is the rate of
permeation (µg/sec), C0 is the initial concentration (µg/ml)
and A is surface area of the monolayer (cm2).
Statistics
Data analysis was performed using GraphPad Prism V9
(GraphPad software Inc, USA). Data are presented as mean ±
standard error of mean (SEM) of 3 independent experiments,
performed in triplicate unless otherwise stated. Statistical
analysis was performed as stated in figure legends. Differences
between variables were considered statistically significant for
p-values < 0.05 and are represented as follows: n/s = not
significant, *p < 0.05, **p < 0.01 and ***p < 0.001.RESULTS
ICAM-1 and ICAM-2 Are Differentially
Expressed on Healthy Lung Epithelium
The mechanisms by which neutrophils transmigrate across
inflamed airway epithelium are ill-defined and the role of
ICAM-1 and ICAM-2 in mediating neutrophil TEpM is
unknown. We initially examined human lungs for ICAM-1 and
ICAM-2 expression on the epithelium. Immunohistochemical
analysis of healthy adult human lungs revealed that ICAM-1 wasFrontiers in Immunology | www.frontiersin.org 4primarily expressed on the alveolar epithelium and only mildly on
the bronchial epithelium (Figure 1A). ICAM-2 was strongly
expressed on the bronchial epithelium and weakly on the alveolar
epithelium (Figure 1A), indicating that ICAM-1 and ICAM-2 are
differentially expressed on healthy adult human lung epithelium.
ICAM-2 Is Up-Regulated on the Bronchial
Epithelium During Neutrophilic
Inflammatory Lung Diseases
We next examined whether inflammatory conditions could affect
ICAM-1 or ICAM-2 expression on the bronchial epithelium.
Normal human adult lungs expressed much lower levels of
ICAM-1 than ICAM-2 on the bronchial epithelium as marked
by CK5 positive staining (Figure 1B). Interestingly, there was
striking up-regulation of ICAM-2 expression in the airways from
patients with CF (a genetic disease characterized by neutrophilic-
driven lung inflammation) compared to normal lung (Figure 1B).
ICAM-1 expression was moderately increased on CF bronchial
epithelium compared to normal lung (Figure 1B). However, only
modestly increased levels of ICAM-1 and ICAM-2 expression were
found on inflamed bronchial epithelium from patients with COPD
(another lung disease characterized with neutrophilic-driven
inflammation) compared to normal lung (Figure 1B). These
observations indicated that ICAM-1 and ICAM-2 expression may
be up-regulated during certain inflammatory lung diseases that are
associated with airway neutrophilia.
Bronchial Epithelial Cells Grown at ALI
Showed Up-Regulation of ICAM-2
Expression Upon Stimulation With TNF-a
As ICAM-2 and ICAM-1 expression were increased on lung
epithelium from patients with an inflammatory lung disease
associated with airway neutrophilia, we next examined whether
these cell adhesion ligands mediate neutrophil TEpM. To model
neutrophil TEpM in a physiological basal-apical direction, an in
vitro model system in which epithelial cells were grown on the
undersurface of a trans-well insert was used (Figure 2A). The
distribution of ICAMs in monolayers of a normal bronchial
epithelial cell line, 16HBE14o- (16HBE) or primary human lung
bronchial epithelial cells (HBECs) was assessed. Similar to our
previous observations, unstimulated 16HBE or HBECs had low
ICAM-1 expression (Figure 2B), which was modestly increased
after TNF-a stimulation of HBECs (Figure 2B). ICAM-1 mRNA
was also detected in unstimulated 16HBE or HBECs by qPCR
analysis, however these levels were ~7-30 fold lower than in
unstimulated human umbilical vein endothelial cells (HUVECs)
(Figure 2C). HUVECs treated with TNF-a lead to a significant
increase in ICAM-1 mRNA expression (Figure 2C) consistent
with previous data (24). In contrast, ICAM-1 mRNA expression
in TNF-a stimulated 16HBE or HBECs did not significantly
differ compared to media treated controls (Figure 2C).
Unstimulated 16HBE or HBECs expressed basal levels of
ICAM-2 protein, which was dramatically increased upon TNF-a
stimulation (Figure 2D). In agreement with the previous data
(25), TNF-a stimulated HUVECs exhibited significantly
decreased expression of ICAM-2 mRNA compared to
unstimulated cells (Figure 2E). TNF-a stimulation of 16HBEAugust 2021 | Volume 12 | Article 691957
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compared to unstimulated controls (Figure 2E), which supports
our immunofluorescence studies showing increased ICAM-2
protein under these conditions. This demonstrated that whilst
TNF-a treatment only had mild effects on ICAM-1 mRNA or
protein expression in bronchial epithelial cells, this pro-
inflammatory mediator had differential effects on ICAM-2
expression, leading to significant up-regulation of protein and
mRNA expression on bronchial epithelial cells.
Neutrophil Migration Across Bronchial
Epithelial Cells Required b2 Integrins and
ICAM-1, but Not ICAM-2
The role of ICAM-2 in human neutrophil TEpMwas next assessed
in response to the recognized neutrophil chemoattractant, fMLP
(26). Pre-treating human neutrophils with blocking antibodies
against b1 or b2 integrins showed that TEpM through a tightFrontiers in Immunology | www.frontiersin.org 5monolayer of 16HBEwasmediated primarily throughb2 integrins,
as b2 integrin blockade significantly reduced neutrophil TEpM
compared to the matched isotype control treated cells (Figure 3A).
Combined b1 and b2 integrin blockade on neutrophils did not
further reduce neutrophil TEpM compared to b2 integrin only
inhibition, strongly supporting the role ofb2 integrins inmediating
neutrophil transmigration (Figure 3A). Specifically, TEpM was
dependent on aLb2 (LFA-1) and aMb2 (Mac-1) expressed on
neutrophils, both integrins that can bind ICAM-1 and ICAM-2
(Figure 3A). To identify the basolateral receptor for these integrins,
bronchial epithelial cell monolayers were pre-treated on the basal
sidewithblocking antibodies against cell adhesion ligands. ICAM-1
blockade, with a D-1 antibody that specifically inhibits LFA-1:
ICAM-1 binding, significantly decreased neutrophil TEpM,
whereas ICAM-2 or VCAM-1 (CD106; another cell adhesion
molecule expressed on epithelial cells) blockade had no effect on
neutrophil TEpM compared to isotype control treated cellsA
B
FIGURE 1 | ICAM-2 is expressed on healthy human bronchial epithelium and is up-regulated in inflamed diseased airways. (A) ICAM-1 or ICAM-2 expression (red)
was visualized on bronchial (top row) or alveolar (bottom row) epithelium in human normal lung tissue by immunohistochemistry. (B) ICAM-1 (red, top row) or ICAM-2
expression (red, bottom row) was visualized on CK5+ epithelium (green) by immunofluorescent staining in human normal lung or diseased CF or COPD lung tissue.
Representative images from 3 normal, 3 CF and 3 COPD lung donors are shown and size is denoted by scale bar.August 2021 | Volume 12 | Article 691957




FIGURE 2 | ICAM-2 expression is up-regulated on bronchial epithelial cells following TNF-a stimulation in vitro. (A) Schematic of 16HBE14o- or HBECs monolayers
grown at ALI using a trans-well in vitro system. Solid arrows denote transverse (TP) or sagittal planes (SP) used for sectioning for later immunofluorescence studies.
(B) Immunofluorescent staining of ICAM-1 expression (red) on unstimulated or TNF-a stimulated CK5+ (green) 16HBE14o- or HBECs grown at ALI. Representative
images are shown on the TP and image size is denoted by the scale bar. (C) ICAM-1 mRNA expression was determined in media (n=5 different passage) or TNF-a
stimulated (n=5-6 different passages) 16HBE14o- or HBECs grown at ALI or HUVECs by qPCR. Fold change in ICAM-1 gene expression was normalised to 2
reference genes. (D) Immunofluorescent staining of ICAM-2 expression (red) was determined on unstimulated or TNF-a stimulated CK5+ (green) 16HBE14o- or
HBECs grown at ALI. Representative images are shown on the TP or SP. Additional DAPI nuclear staining (blue) was performed on sections on the SP. Image size
is denoted by the scale bar. (E) ICAM-2 mRNA expression was determined in media (n=5-7 different passages) or TNF-a stimulated (n=4-6 different passages)
16HBE14o- or HBECs grown at ALI or HUVECs by qPCR. Fold change in ICAM-2 gene expression was normalised to 2 reference genes. All statistical testing was
performed using paired t-test and any differences are indicated (n/s, not significant, *p < 0.05, **p < 0.01).Frontiers in Immunology | www.frontiersin.org August 2021 | Volume 12 | Article 6919576




FIGURE 3 | Neutrophil trans-epithelial migration towards fMLP required b2 integrins and ICAM-1 but not ICAM-2. (A) Neutrophil TEpM through 16HBE14o- ALI
monolayers were assessed using media, blocking antibodies (anti-b1, b2, aM, a4 or aL) or matched IgG1 or IgG2a isotype controls pre-treated neutrophils (n=3
donors). Percentage of transmigrated neutrophils was calculated relative to transmigrated unstimulated neutrophils (control). (B) Neutrophil TEpM (n=3 donors)
was assessed through 16HBE14o- ALI monolayers pre-treated on the basolateral side with IgG1 isotype control or blocking antibodies against ICAM-1, ICAM-2
or VCAM-1. Percentage of transmigrated neutrophils was calculated relative to migrated neutrophils through unstimulated monolayers (control). (C) Neutrophil TEpM
(n=3 donors) was assessed through 16HBE14o- ALI monolayers pre-treated on the basolateral side with media, IgG1 isotype control or blocking antibodies against
ICAM-1, ICAM-2 or both together. Percentage of transmigrated neutrophils was calculated relative to migrated neutrophils through unstimulated monolayers (control).
(D) 16HBE14o- ALI monolayers were pre-treated with media or 50 ng/ml TNF-a for 24 h. The basolateral side of the monolayers were then either treated with media,
IgG1 isotype control or blocking antibodies against ICAM-1, ICAM-2 or both. Neutrophil TEpM (n=3 donors) was assessed relative to migrated neutrophils through
unstimulated monolayers (control). Any statistical differences were determined using 1-way ANOVA with Holm-Sidak post-hoc correction (n/s, not significant,
*p < 0.05, **p < 0.01, ***p < 0.001). Asterisks above bars show comparisons to matched IgG controls, unless stated otherwise.Frontiers in Immunology | www.frontiersin.org August 2021 | Volume 12 | Article 6919577
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epithelial cells exhibited low ICAM-1 expression compared to
much higher levels of ICAM-2. ICAM-1 and ICAM-2 combined
blockade did not further reduce neutrophil TEpM compared to
ICAM-1 only inhibition suggesting that ICAM-2 was redundant in
mediating neutrophil migration in vitro (Figure 3C). To ensure
ICAM-2 expression was maximized on bronchial epithelial cells,
monolayers were pre-stimulated with TNF-a, and under these
conditions neutrophil TEpM was still dependent on ICAM-1
with no role for ICAM-2 in this neutrophil TEpM in vitro
model (Figure 3D).
Neutrophil TEpM Affects Bronchial
Epithelial Integrity
As ICAM-1 significantly contributed to neutrophil TEpM in vitro,
we next investigated the integrity of the bronchial epithelial cell
monolayers by measuring epithelial permeability before and after
neutrophil TEpM. Untreated bronchial epithelial cell monolayers
had a high trans-epithelial resistance (TEER) of 3487W ± 152.9W,
however after 3 h of neutrophil TEpM, theTEER fell significantly to
1912.3W± 27.9W compared to untreatedmonolayers (Figure 4A).
The permeability to Na+ ions and 3 KDa dextran also increased
significantly by 75% and 33% respectively compared to untreated
monolayers (Figures 4B, C). Furthermore, when bronchial
epithelial cell monolayers were pre-treated with 50 ng/ml TNF-a
before neutrophil TEpM, the TEER was not significantly different
compared to unstimulated bronchial epithelial cell monolayers
following neutrophil TEpM (Figure 4D). This demonstrated that
neutrophils themselves significantly increase the permeability of
either unstimulated or TNF-a treated epithelialmonolayers as they
move across but the tight junctions in these fully differentiated
monolayer of cells are still maintained as the TEER was
approximately 2000 W.
ICAM-1 and ICAM-2 Are Differentially
Expressed on Naïve Wild-Type Murine
Lung Epithelium
As our in vitro data suggested that human neutrophil bronchial-
TEpM was dependent on ICAM-1 and independent of ICAM-2Frontiers in Immunology | www.frontiersin.org 8expression, a mouse model of sterile inflammation was used to
confirm these findings in vivo. Basal expression of ICAM-1 and
ICAM-2 on naive murine lung epithelium were initially studied.
ICAM-1 was expressed in blood vessels, as supported by
earlier reports (27) and also strongly expressed on the alveolar
epithelium and to a lesser extent on the bronchial epithelium
(Figure 5A). ICAM-2 was found to be mildly expressed on
the endothelium (Figure 5B), a previously known observation
(27) and more strongly expressed on the bronchial epithelium
than the alveolar epithelium (Figure 5B). Staining of naive
murine lung with matched isotype control antibodies revealed
minimal non-specific binding of ICAM-1 or ICAM-2 antibody
(Figures 5A, B). Overall, ICAM-1 and ICAM-2 were differentially
expressed on the alveolar or bronchial epithelium of naïve murine
lungs, mirroring our earlier observations in normal human
adult lung.
Neutrophil Recruitment Into the Airways
or Lungs Is Independent of ICAM-2 in an
Animal Model of Sterile Inflammation
To confirm our in vitro data showing neutrophil TEpM was
ICAM-2 independent, the role of ICAM-2 in neutrophil TEpM
was investigated in vivo using mice lacking global ICAM-2
expression in an established model of LPS-induced sterile
inflammation model. Inhaled LPS can lead to neutrophil
recruitment into the airways (28). Treatment of ICAM-2 WT
or KO mice with inhaled LPS lead to significant recruitment of
neutrophils and macrophages into the BALF compared to PBS-
treated mice after 24 h (Figures 6A, B). However, there was no
significant difference between LPS-treated ICAM-2 WT or KO
mice (Figures 6A, B). In addition, neutrophils and monocyte-
derived macrophages (MDMs) were significantly recruited into
LPS-treated lungs compared to PBS treated controls (Figures 6C, E).
Alveolar macrophages (AMs) were significantly reduced in
LPS-treated lungs compared to PBS controls and numbers of
monocytes were unchanged (Figures 6D, F). Similar to our
observations in the BALF, there were no significant differences
in recruited cells into the lung between LPS-treated ICAM-2 WT
or KO mice (Figures 6C–F). Overall, this suggested that ICAM-2A B DC
FIGURE 4 | Neutrophil transmigration affects bronchial epithelial cell integrity. (A) TEER or permeability to (B) sodium-fluorescein or (C) 3 KDa Dextran-FITC was
measured before (0 h) and after 3 h of neutrophil TEpM (nj TEpM) through 16HBE14o- ALI cultures. Wells with fMLP and without neutrophils were used as a control
group. (D) TEER was measured before (0 h) and after 3 h neutrophil TEpM through either unstimulated 16HBE14o- ALI cultures (u/s 16HBE ! nj TEpM) or TNF-a
stimulated 16HBE14o- ALI cultures (TNF-a 16HBE ! nj TEpM). Statistical testing was performed using 2-way ANOVA with Holm-Sidak post-hoc correction or
unpaired student t-test (n/s, not significant, *p < 0.05, **p < 0.01, ***p < 0.001). Asterisks above bars show comparisons to 0 h controls, unless stated otherwise.August 2021 | Volume 12 | Article 691957
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airways or lung in vivo.
ICAM-1 Mediates Macrophage
Recruitment Into the Lung but Is Not
Required for Neutrophil TEpM Into the
Airways In Vivo
It has been reported, using KO mice, that LFA-1: ICAM-1
interactions mediate approximately 50% of neutrophilFrontiers in Immunology | www.frontiersin.org 9recruitment into the alveolar space during inflammation in vivo
(29). To ensure that LFA-1:ICAM-1 interactions were not
compensating for a lack of ICAM-2 in our animal model of
sterile inflammation, ICAM-2 WT and KO mice were pre-treated
with a blocking antibody directed against D1 of ICAM-1, the site
for LFA-1 binding, before LPS challenge. Staining of murine lungs
with an anti-isotype secondary antibody confirmed the ICAM-1
blocking antibody had reached the alveolar space (Supplemental
Figure 4). Interestingly, LFA-1:ICAM-1 blockade did notA
B
FIGURE 5 | ICAM-1 and ICAM-2 are differentially expressed on wild-type murine lung epithelium. (A) ICAM-1 expression (red) was visualized in wild-type murine
normal lung tissue by immunohistochemistry. (B) ICAM-2 expression (red) was visualized in wild-type murine normal lung tissue by immunohistochemistry. Minimal
non-specific primary antibody binding was detected by staining with matched IgG isotype control antibody. Representative images are shown and size is denoted by
the scale bar (A, alveoli; B, bronchiole; BV, blood vessel).A B
D E FC
FIGURE 6 | Neutrophil recruitment into the airways or lungs is independent of ICAM-2 during sterile inflammation in vivo. (A, B) ICAM-2 WT (n=8 per treatment
group) or ICAM-2 KO (n=7 per treatment group) mice were challenged with 3.3 mg LPS or PBS via intranasal instillation for 24 h. Quantification of neutrophils or
macrophages from recovered BALF was determined by cell counts from cytospins. (C–F) Quantification of recruited neutrophils, monocytes, monocyte-derived
macrophage (MDM) or alveolar macrophages (AM) populations in the lung was determined from single cell lung homogenates by flow cytometric analysis. Any
significant differences were determined using 2-way ANOVA statistical testing with Holm-Sidak post-hoc correction (n/s, not significant, **p < 0.01, ***p < 0.001).
Asterisks above bars indicate significant differences compared to PBS-treated genotype unless stated otherwise.August 2021 | Volume 12 | Article 691957
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recruited into the BALF of ICAM-2 WT or KO mice compared to
isotype treated controls (Figures 7A, B). In addition, LFA-1:
ICAM-1 blockade had no effect on neutrophil or monocyte
recruitment to the lungs in either ICAM-2 WT or KO mice
compared to isotype treated controls (Figures 7C, D). However,
LFA-1:ICAM-1 blocking antibody treatment significantly reduced
the numbers of recruitedMDMs and AMs in the lungs of ICAM-2
WTmice (Figures 7E, F) but this effect was not seen in the ICAM-
2 KO mice (Figures 7E, F). This suggested that although ICAM-1
and ICAM-2 do not mediate neutrophil recruitment, they may
interact in a complex manner to mediate macrophage recruitment
into inflamed lungs in vivo.DISCUSSION
The pulmonary circulation is the largest vascular bed in the body
and the lung contains a large marginated pool of neutrophils
(30), ready to mount a rapid immune response against infection.
Neutrophil recruitment during pulmonary inflammation is
characterized by sequential steps from exiting the blood across
the endothelium and into the lung interstitium (31). How
neutrophils exit the lung across the epithelium is less well
understood and the requirements for ICAM-1 or ICAM-2 in
this process are ill-defined.
We found differential expression of ICAM-1 and ICAM-2 on
healthy human and murine lung epithelium, with ICAM-1
expression more prominent on alveolar epithelium and more
ICAM-2 found on the bronchial epithelium. ICAM-1 and
ICAM-2 expression levels were also up-regulated in lungs from
patients with inflammatory lung diseases associated with airway
neutrophilia such as CF and to a lesser extent, COPD. These
findings agreed with literature demonstrating up-regulation ofFrontiers in Immunology | www.frontiersin.org 10ICAM-1 expression on bronchial epithelium during chronic
inflammation (32, 33). Although, recent single-cell
transcriptomics of healthy human lung have indicated that
alveolar type I and II cells have the highest icam1 expression
(34). Human bronchial epithelial cells stimulated with TNF-a
showed increased ICAM-2 mRNA and protein expression
in vitro, although the evidence for ICAM-2 expression in the
lung is conflicted. Our observation of strong bronchial epithelial
ICAM-2 expression agrees with previous studies demonstrating
ICAM-2 expression on human bronchial epithelial cells (21, 35).
However, other studies have found no or very weak ICAM-2
expression in human lung epithelium (34, 36). This discrepancy
with our results could be due to the lung tissue from heavy
smokers used by González et al., which may affect ICAM-2
expression. It is still unclear why there is differential ICAM-1 and
ICAM-2 expression on lung epithelium, one possible explanation
could be regulated neutrophil exit from the interstitium for
immune clearance by the mucociliary escalator via the
bronchial epithelium (37) or to promote tissue repair via the
alveolar epithelium (38, 39).
Whilst, the mechanisms of neutrophil trans-endothelial
migration are well characterized, the role of cell adhesion
molecules such as b2 integrins and ICAMs in neutrophil
TEpM are ill-defined and sometimes contradictory. Tight
epithelia are highly polarized and biochemical and imaging
studies have shown that ICAM-1 is apically restricted on gut
epithelial cells and does not play a role in leukocyte TEpM (40).
The same was assumed to be true for the bronchial epithelium.
However, we and others (41) have previously shown, with
confocal and functional data, that although ICAM-1 and
ICAM-2 are both polarized, both are expressed on the
basolateral and to a greater extent, the apical surfaces, with a
marked basal-to-apical gradient on bronchial epithelial cells (21).
In this current work we show that neutrophil TEpM across aA
D E FC
FIGURE 7 | Neutrophil recruitment into the airways or lungs is independent of both LFA-1: ICAM-1 and ICAM-2 interactions during inflammation. (A, B) ICAM-2 WT or
KO mice were pre-treated with 2 doses of 3 mg/kg IgG2a isotype control (n=4 WT or KO) or ICAM-1 blocking antibody (n=5 WT or KO) prior to intranasal challenge with
3.3 mg LPS for 24 h. Quantification of neutrophils or macrophages from recovered BALF was determined by cell counts from cytospins. (C–F) Quantification of recruited
neutrophils, monocytes, monocyte-derived macrophages (MDM) or alveolar macrophages (AM) populations into the lung was determined from single cell lung homogenates
by flow cytometric analysis. Any significant differences were determined using 2-way ANOVA statistical testing with Holm-Sidak post-hoc correction (n/s, not significant,
*p < 0.05). Asterisks above bars indicate significant differences compared to PBS-treated genotype unless stated otherwise.August 2021 | Volume 12 | Article 691957
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ICAM-1 and b2-integrin dependent as supported by other
studies (17–19) with no contribution from ICAM-2, despite
high expression of this ligand.
Our previous work showed that lymphocyte migration across
a bronchial epithelial monolayer is a multistep process
dependent on LFA-1 adhesion to basolateral ICAM-1 and
ICAM-2 and leukocyte migration along an ICAM gradient.
This gradient guides lymphocytes into the paracellular space
for negotiation of the tight junctions, so called ‘junctional
recognition’. It is likely that ICAM-1 is playing a similar role
in neutrophil TEpM across a ‘tight’ epithelium. This step may be
less important in a leaky epithelium where junctional integrity
has been compromised and crossing the junctions is no longer
a rate-limiting step. This may explain the recent observation
that when the interactions between LFA-1 on neutrophils and
ICAM-1 on respiratory syncytial virus (RSV)-infected nasal
airway epithelial cells were inhibited, this led to deceased
neutrophil adhesion to the epithelial cells with no effect on
subsequent neutrophil TEpM (42). We previously showed that
apical ICAM-1 is not required for TEpM for lymphocytes but
does play a role in leukocyte retention in the airway (21).
Interestingly, here we also showed that neutrophil TEpM itself
increases barrier permeability, perhaps in an ICAM-1/myosin
light chain kinase dependent manner (43). This suggests that in
the face of epithelial barrier disruption as may occur during
overwhelming infection, inflammation or TEpM of large
numbers of neutrophils, other cell adhesion molecules or
extrinsic factors, such as chemokine gradients, may mediate
the movement of neutrophils out into the airways.
The requirement for LFA-1: ICAM-1 in neutrophil
recruitment into the airways and lung during LPS-induced
pulmonary inflammation in vivo has been previously described
(29, 44). These studies contrast with our findings where blockade
of LFA-1: ICAM-1 in ICAM-2 wild-type mice did not
significantly affect neutrophil recruitment into the lung or
broncho-alveolar space after LPS chal lenge. These
discrepancies in results could be due to our higher dose of LPS
used to induce inflammation, which may disrupt the epithelial
barrier (45), so reducing the requirement for ICAM-1 for TEpM.
It should also be noted that our choice of ICAM-1 blocking
antibody (clone KAT-1) has been shown to bind to the D-1
domain of ICAM-1 to prevent LFA-1 binding to ICAM-1 (46),
therefore we cannot exclude the possibility that neutrophils may
still be able to bind to domain 3 of ICAM-1 via Mac-1 in the
presence of clone KAT-1 in our animal experiments. However,
Basit et al., and Kumasaka et al., also used an ICAM-1 D-1
blocking antibody and have reached a different conclusion (29,
44). Work by Petrovich et al., has addressed this same question
using ICAM-1-/- mice to avoid the complications with ICAM-1
blocking antibodies. Despite their different approach and the
absence of Mac-1:ICAM-1 interactions, they show, as we have
here, that epithelial ICAM-1 is not required for TEpM in sterile
inflammation (27).
The discrepancy between these in vivo results and the
consistent in vitro demonstrations of a role for ICAM-1 inFrontiers in Immunology | www.frontiersin.org 11neutrophil TEpM across an intact bronchial epithelial barrier
with high (> 2000 W) TEER support the concept that ICAM-1
may only regulate TEpM through an intact barrier or during
milder inflammation. Furthermore it should also be noted that
ICAM-1 may have other roles aside from cellular recruitment
such as bacterial killing as seen in a pneumococcal infection
model (although migration into the alveolar space was not
assessed) (47) or activating NK cells to induce cell lysis during
infection (48).
The role of ICAM-2 in mediating neutrophil TEpM has not
been fully elucidated, although ICAM-2 facilitates lymphocyte
(21) and eosinophil TEpM (15). We found very little
requirement for ICAM-2 for neutrophil TEpM in vitro or
in vivo, despite abundant expression on lung bronchial epithelium.
In addition, we found the loss of ICAM-1 and ICAM-2 does not
impact cellular recruitment into the airways or lung in response to
pneumococcal bacterial infection (Supplemental Figure 3). Our
results support Petrovich et al., who found that during strong
inflammatory conditions such as LPS treatment when the
epithelial barriers are disrupted, ICAM-1 and ICAM-2 are not
required for neutrophil TEpM (27). In addition, Petrovich et al.,
also found significantly more neutrophils entrapped in the lungs of
PBS-treated ICAM-1/ICAM-2 double knockout mice compared to
PBS-treated wildtype controls and very few neutrophils recovered in
the BAL (27). This would support our hypothesis that when the
epithelial barrier is intact, ICAM-1 and/or ICAM-2 may be required
for basal or constitutive trafficking of neutrophils out of the lung and
into the airways.
As our in vivo data suggested that neutrophil recruitment into
the lung or airways during inflammation is ICAM-1 and ICAM-
2 independent, other adhesion molecules may play a more
dominant role in neutrophil trafficking. One possibility is that
neutrophil recruitment in vivo is driven by selectins such as
E- and L-selectin (49). TREM-1 expressed on neutrophils has
been shown to be required for TEpM during P. aeruginosa
infection and for control of bacterial spread (50). However, the
epithelial ligand for TREM-1 was not identified in this study.
In addition, neutrophil TEpM has shown to be dependent on
neutrophil expressed Mac-1 and JAM-A on the colonic
epithelium (51), whether a similar mechanism also occurs in
the lung is currently unknown.
It should also be noted that ICAM-1 and ICAM-2 may drive
pulmonary recruitment of other leukocytes such as T cells. We
have previously shown T cells use ICAM-1 and ICAM-2 for
TEpM in vitro (21). However, ICAM-1 deficient mice exhibit
reduced lymphocyte trapping in naive lung and additional
ICAM-2 blockade did not further reduce lymphocyte numbers
in the lung (52). It is still unknown the role these ligands play in
lymphocyte TEpM during in vivo inflammation or infection. In
addition, we showed ICAM-1 is required for MDM recruitment
into inflamed lung as supported by in vitro studies
demonstrating ICAM-1 dependent monocyte trans-endothelial
migration (53). However, macrophages are still found in similar
numbers in the lavage despite ICAM-1 blockade. ICAM-1 may
play a role in leukocyte retention at the luminal epithelial surface,
so that despite reduced numbers at this site; a higher percentageAugust 2021 | Volume 12 | Article 691957
Chong et al. Leukocyte Migration Across Bronchial Epitheliumof cells are dislodged and found in the lavage. Intriguingly this
effect is not seen in ICAM-2 KO mice, where ICAM-1 blockade
has no effect on leukocyte recruitment to the interstitium. The
fact that ICAM-2 deletion rescues the effect of ICAM-1 blockade
may reflect the fact that monocytes also express ICAM-2 (7)
required for cellular trafficking and this remains the focus of
future work.
Overall, we have demonstrated for the first time, the differential
expression of ICAM-1 and ICAM-2 on healthy adult human and
murine lung epithelium and up-regulation of these ligands during
inflammation and inflammatory lung diseases. Our studies
demonstrated that neutrophil TEpM through an intact human
bronchial epithelial cell monolayer is ICAM-1 and b2 integrin-
dependent and neutrophil TEpM itself reduced bronchial
epithelial barrier integrity. In addition, we have made the
observation that neutrophil recruitment into the lung or airways
is ICAM-2 independent during pulmonary sterile inflammation,
and ICAM-2 deficiency is not compensated for by LFA-1: ICAM-1
interactions. This suggests that other mechanisms facilitate
neutrophil exit into the airways in the absence of LFA-1: ICAM-1
and ICAM-2 during an inflammatory response.DATA AVAILABILITY STATEMENT
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